|Articles|March 23, 2021
Superior Monoclonality Assurance for a Successful IND
Author(s)Berkeley Lights, Inc.
Used by leading pharma companies and CDMOs, the Beacon system offers an integrated end-to-end automated workflow for mammalian cell line development. Clones can be selectively enriched for unique phenotypes and multiple assays can be used to rapidly measure productivity of different antibody molecules.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
2
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
3
Pharma Tariff FAQ: Costs, Supply Chains, Policy for 2025
4
A Simple Step-by-Step Protocol for Hydrophilic Interaction Liquid Chromatography (HILIC) Development
5
